Bruton Tyrosine Kinase (BTK) inhibitor

News

An early-stage drug that is being developed to tackle inflammatory and autoimmune diseases has been approved by the US regulator.

News

Shares in Vaxcyte have rocketed on phase 3 trial data for its pneumococcal vaccine VAX-31 that suggests it could take on rivals from Pfizer and MSD.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.